{
    "hands_on_practices": [
        {
            "introduction": "This first practice is a fundamental exercise in pharmacokinetics, focusing on the concept of clearance. By analyzing hypothetical data from a steady-state infusion, you will learn to calculate both total body clearance and the specific contribution of the kidneys, mastering the core principles of mass balance in a clinical context. This skill is essential for understanding how a drug is eliminated from the body .",
            "id": "4972402",
            "problem": "A drug is administered by constant intravenous infusion to a $70$ kg adult and has reached steady state. The steady-state plasma concentration is $5.0$ mg/L. The infusion rate is $30$ mg/h. A timed urine collection obtained during steady state shows a urine drug concentration of $200$ mg/L and a urine flow rate of $1.5$ mL/min. The drug exhibits plasma protein binding of $80\\%$ (unbound fraction in plasma $= 0.20$). The patientâ€™s Glomerular Filtration Rate (GFR) is $120$ mL/min. Assume linear pharmacokinetics, that the urine collection and plasma concentration reflect the same steady-state period, and that the measured urinary drug is the unchanged parent compound.\n\nUsing only first principles (mass balance and the definition of clearance), compute:\n1) the renal clearance, and\n2) the fraction of total elimination that occurs as unchanged drug in urine.\n\nExpress the renal clearance in mL/min and the fraction as a unitless decimal (not a percentage). Round both to three significant figures.",
            "solution": "The problem requires the calculation of two pharmacokinetic parameters using first principles: the renal clearance ($CL_R$) and the fraction of the drug that is eliminated unchanged in the urine ($f_e$). The problem is valid as it is scientifically grounded, self-contained, and well-posed.\n\nThe givens for the calculation are:\n- Steady-state plasma concentration, $C_{ss} = 5.0$ mg/L\n- Infusion rate, $R_0 = 30$ mg/h\n- Urine drug concentration, $C_u = 200$ mg/L\n- Urine flow rate, $Q_u = 1.5$ mL/min\n\n**1. Calculation of Renal Clearance ($CL_R$)**\n\nBy definition, renal clearance is the volume of plasma cleared of the drug by the kidneys per unit time. It is calculated as the rate of urinary excretion of the drug ($R_e$) divided by the plasma concentration of the drug ($C_{ss}$).\n\nFirst, we calculate the rate of excretion ($R_e$) from the urine data. The rate of excretion is the product of the urine drug concentration ($C_u$) and the urine flow rate ($Q_u$).\n$$R_e = C_u \\times Q_u$$\nThe renal clearance is then given by:\n$$CL_R = \\frac{R_e}{C_{ss}} = \\frac{C_u \\times Q_u}{C_{ss}}$$\nWe are given $C_u = 200$ mg/L, $Q_u = 1.5$ mL/min, and $C_{ss} = 5.0$ mg/L. Substituting these values into the equation for $CL_R$:\n$$CL_R = \\frac{(200 \\text{ mg/L}) \\times (1.5 \\text{ mL/min})}{5.0 \\text{ mg/L}}$$\nThe concentration units (mg/L) in the numerator and denominator cancel, leaving the units of mL/min, which is appropriate for clearance.\n$$CL_R = \\frac{300}{5.0} \\text{ mL/min} = 60 \\text{ mL/min}$$\nThe problem requests the answer rounded to three significant figures, so $CL_R = 60.0$ mL/min.\n\n**2. Calculation of the Fraction of Elimination as Unchanged Drug in Urine ($f_e$)**\n\nThe fraction of drug eliminated unchanged in urine, $f_e$, is defined as the ratio of the renal clearance ($CL_R$) to the total body clearance ($CL_T$).\n$$f_e = \\frac{CL_R}{CL_T}$$\nTo determine $f_e$, we must first calculate the total body clearance, $CL_T$. At steady state, the fundamental principle of mass balance states that the rate of drug administration equals the rate of drug elimination. The drug is administered at a constant infusion rate, $R_0$. The total rate of elimination from the body is the product of the total body clearance ($CL_T$) and the steady-state plasma concentration ($C_{ss}$).\n$$R_0 = \\text{Rate of Elimination} = CL_T \\times C_{ss}$$\nWe can rearrange this equation to solve for $CL_T$:\n$$CL_T = \\frac{R_0}{C_{ss}}$$\nWe are given $R_0 = 30$ mg/h and $C_{ss} = 5.0$ mg/L.\n$$CL_T = \\frac{30 \\text{ mg/h}}{5.0 \\text{ mg/L}} = 6.0 \\text{ L/h}$$\nTo maintain consistency with the units of $CL_R$ (mL/min), we must convert the units of $CL_T$.\n$$1 \\text{ L} = 1000 \\text{ mL}$$\n$$1 \\text{ h} = 60 \\text{ min}$$\nSo, the conversion factor is $\\frac{1000 \\text{ mL/L}}{60 \\text{ min/h}}$.\n$$CL_T = 6.0 \\frac{\\text{L}}{\\text{h}} \\times \\frac{1000 \\text{ mL}}{1 \\text{ L}} \\times \\frac{1 \\text{ h}}{60 \\text{ min}} = \\frac{6000}{60} \\frac{\\text{mL}}{\\text{min}} = 100 \\text{ mL/min}$$\nNow we can calculate $f_e$ using the values of $CL_R$ and $CL_T$:\n$$f_e = \\frac{CL_R}{CL_T} = \\frac{60 \\text{ mL/min}}{100 \\text{ mL/min}} = 0.6$$\nThe result is a unitless fraction, as required. The problem requests this value be rounded to three significant figures, so $f_e = 0.600$.\n\nThe other provided information (patient weight, protein binding, GFR) is not required for answering the questions as posed but serves to confirm the physiological plausibility of the scenario. The calculated results are consistent with these data.",
            "answer": "$$ \\boxed{ \\begin{pmatrix} 60.0  0.600 \\end{pmatrix} } $$"
        },
        {
            "introduction": "Building on the general concept of clearance, this problem zooms in on the liver, a primary site of drug metabolism. You will derive and apply the \"well-stirred\" model to understand how hepatic blood flow ($Q_h$) and the liver's intrinsic metabolic capacity ($CL_{int}$) jointly determine hepatic clearance. This exercise illustrates why predicting drug-drug interactions and the effects of physiological changes is critical in therapy .",
            "id": "4972433",
            "problem": "A low-dose oral drug is cleared predominantly by the liver and follows linear, non-saturable metabolism under the well-stirred (venous equilibrium) model. Assume instantaneous equilibrium between hepatocyte unbound concentration and hepatic venous concentration, negligible extrahepatic clearance, and constant hepatic blood flow. You are given hepatic blood flow $Q_h=90$ L/h, fraction unbound in plasma $f_u=0.1$, and intrinsic clearance $CL_{int}=500$ L/h.\n\nStarting from the mass-balance definition of hepatic extraction ratio $E_h$ as the fraction of drug removed in a single pass and the relationship between the rate of hepatic elimination and intrinsic clearance acting on the unbound concentration, derive an expression for $E_h$ in terms of $Q_h$, $f_u$, and $CL_{int}$ without assuming any shortcut formulas. Then, compute the numerical values of $E_h$ and hepatic clearance $CL_h$, and predict the effect on $CL_h$ of a $50\\%$ reduction in $Q_h$ (i.e., the new $Q_h$ equals $0.5\\,Q_h$).\n\nRound each numerical result to four significant figures. Express $CL_h$ in L/h. Your final reported values should be $E_h$ (unitless), $CL_h$ at baseline $Q_h$ in L/h, and $CL_h$ after $50\\%$ reduction in $Q_h$ in L/h, in that order.",
            "solution": "The problem statement is evaluated as valid. It is scientifically grounded in the principles of pharmacokinetics, specifically the well-stirred model of hepatic clearance. It is well-posed, objective, and provides all necessary data ($Q_h=90$ L/h, $f_u=0.1$, $CL_{int}=500$ L/h) for a unique solution. The instructions are clear and the task is to derive a known formula from first principles before applying it, which is a standard academic exercise.\n\nThe solution proceeds in three parts as requested: derivation of the expression for the hepatic extraction ratio ($E_h$), calculation of numerical values for $E_h$ and hepatic clearance ($CL_h$), and prediction of the change in $CL_h$ following a reduction in hepatic blood flow ($Q_h$).\n\n**Part 1: Derivation of the Hepatic Extraction Ratio ($E_h$)**\n\nThe derivation begins from two fundamental principles: mass balance across the liver and the definition of intrinsic clearance.\n\n1.  **Mass Balance**: The rate of drug elimination by the liver, $R_{el}$, is the difference between the rate of drug entering and leaving the liver via the hepatic blood flow, $Q_h$. Let $C_a$ be the drug concentration in the blood entering the liver (arterial or portal venous) and $C_v$ be the drug concentration in the blood leaving the liver (hepatic venous).\n    $$R_{el} = Q_h C_a - Q_h C_v = Q_h (C_a - C_v)$$\n    The hepatic extraction ratio, $E_h$, is defined as the fraction of drug removed from the blood in a single pass through the liver. It is the rate of elimination divided by the rate of drug presentation to the liver ($Q_h C_a$).\n    $$E_h = \\frac{R_{el}}{Q_h C_a} = \\frac{Q_h (C_a - C_v)}{Q_h C_a} = \\frac{C_a - C_v}{C_a} = 1 - \\frac{C_v}{C_a}$$\n\n2.  **Intrinsic Clearance**: Intrinsic clearance, $CL_{int}$, characterizes the liver's inherent metabolic capacity, independent of blood flow. It relates the rate of elimination to the unbound drug concentration within the hepatocytes, $C_{u,h}$.\n    $$R_{el} = CL_{int} C_{u,h}$$\n    The problem specifies the \"well-stirred\" or \"venous equilibrium\" model. A key assumption of this model is that the liver acts as a single, well-mixed compartment. This implies that the drug concentration throughout the liver sinusoids is uniform and equal to the concentration in the exiting hepatic venous blood, $C_v$. Consequently, the unbound drug concentration in the hepatocytes, $C_{u,h}$, is in instantaneous equilibrium with the unbound drug concentration in the hepatic venous blood.\n    $$C_{u,h} = f_u C_v$$\n    where $f_u$ is the fraction of drug unbound in the plasma (and by extension, blood, assuming a blood-to-plasma ratio of $1$).\n\n    Substituting this into the intrinsic clearance equation gives:\n    $$R_{el} = CL_{int} f_u C_v$$\n\n3.  **Combining the Principles**: We now have two expressions for the rate of elimination, $R_{el}$. Equating them allows us to solve for the relationship between the entering and exiting concentrations.\n    $$Q_h (C_a - C_v) = CL_{int} f_u C_v$$\n    To find an expression for $E_h$, we first rearrange this equation to solve for the ratio $\\frac{C_v}{C_a}$.\n    $$Q_h C_a - Q_h C_v = (f_u CL_{int}) C_v$$\n    $$Q_h C_a = (Q_h + f_u CL_{int}) C_v$$\n    $$\\frac{C_v}{C_a} = \\frac{Q_h}{Q_h + f_u CL_{int}}$$\n    Finally, we substitute this result into the mass-balance definition of $E_h$:\n    $$E_h = 1 - \\frac{C_v}{C_a} = 1 - \\frac{Q_h}{Q_h + f_u CL_{int}}$$\n    $$E_h = \\frac{(Q_h + f_u CL_{int}) - Q_h}{Q_h + f_u CL_{int}}$$\n    $$E_h = \\frac{f_u CL_{int}}{Q_h + f_u CL_{int}}$$\n    This completes the required derivation.\n\n**Part 2: Calculation of Baseline $E_h$ and $CL_h$**\n\nGiven the values:\n$Q_h = 90$ L/h\n$f_u = 0.1$\n$CL_{int} = 500$ L/h\n\nFirst, we calculate the product $f_u CL_{int}$, which represents the unbound intrinsic clearance.\n$$f_u CL_{int} = 0.1 \\times 500 \\text{ L/h} = 50 \\text{ L/h}$$\nNow, we can compute the hepatic extraction ratio, $E_h$.\n$$E_h = \\frac{f_u CL_{int}}{Q_h + f_u CL_{int}} = \\frac{50}{90 + 50} = \\frac{50}{140} = \\frac{5}{14} \\approx 0.3571428...$$\nRounding to four significant figures, $E_h = 0.3571$.\n\nNext, we compute the baseline hepatic clearance, $CL_h$. Hepatic clearance is defined as the volume of blood cleared of drug per unit time, and can be expressed as the product of blood flow and the extraction ratio.\n$$CL_h = Q_h E_h$$\nSubstituting the derived expression for $E_h$:\n$$CL_h = Q_h \\left( \\frac{f_u CL_{int}}{Q_h + f_u CL_{int}} \\right) = \\frac{Q_h f_u CL_{int}}{Q_h + f_u CL_{int}}$$\nUsing the given values:\n$$CL_h = 90 \\text{ L/h} \\times \\frac{5}{14} = \\frac{450}{14} \\text{ L/h} = \\frac{225}{7} \\text{ L/h} \\approx 32.142857... \\text{ L/h}$$\nRounding to four significant figures, $CL_h = 32.14$ L/h.\n\n**Part 3: Prediction of $CL_h$ after Reduction in $Q_h$**\n\nThe hepatic blood flow is reduced by $50\\%$. The new blood flow, $Q_h'$, is:\n$$Q_h' = 0.5 \\times Q_h = 0.5 \\times 90 \\text{ L/h} = 45 \\text{ L/h}$$\nThe intrinsic parameters of the drug and liver, $f_u$ and $CL_{int}$, are assumed to be unaffected by this change in blood flow. We can now calculate the new hepatic clearance, $CL_h'$, using the value of $Q_h'$.\n$$CL_h' = \\frac{Q_h' f_u CL_{int}}{Q_h' + f_u CL_{int}}$$\n$$CL_h' = \\frac{45 \\times 50}{45 + 50} = \\frac{2250}{95} = \\frac{450}{19} \\text{ L/h} \\approx 23.68421... \\text{ L/h}$$\nRounding to four significant figures, $CL_h' = 23.68$ L/h.\n\nThe final results, rounded to four significant figures, are:\n- $E_h = 0.3571$\n- $CL_h$ (baseline) = $32.14$ L/h\n- $CL_h$ (reduced $Q_h$) = $23.68$ L/h\nThis drug has a low-to-intermediate extraction ratio ($E_h \\approx 0.36$). As predicted by the well-stirred model for such drugs, its clearance is sensitive to changes in both blood flow and intrinsic clearance. The $50\\%$ reduction in blood flow resulted in a substantial, though not directly proportional, decrease in hepatic clearance from $32.14$ L/h to $23.68$ L/h.",
            "answer": "$$\\boxed{\\begin{pmatrix} 0.3571  32.14  23.68 \\end{pmatrix}}$$"
        },
        {
            "introduction": "The ultimate goal of pharmacology is to understand a drug's effect, not just its concentration. This final practice bridges pharmacokinetics (PK) and pharmacodynamics (PD) by introducing an effect-site compartment, demonstrating why a delay often exists between peak drug concentration in the plasma and its peak therapeutic effect. Solving this problem will help you appreciate the temporal dynamics of drug action and the importance of PK/PD modeling in optimizing dosing regimens .",
            "id": "4972416",
            "problem": "A single intravenous bolus dose of a drug is administered at time $t=0$ into a patient whose disposition can be described by a one-compartment pharmacokinetic model with first-order elimination. Let the dose be $D=100$ mg and the apparent volume of distribution be $V=10$ L, giving an initial plasma concentration $C_{0}=D/V$. The pharmacokinetic elimination rate constant is $k_{\\text{el}}=0.25$ $\\text{h}^{-1}$. The pharmacodynamic (PD) effect is driven by an effect-site (biophase) compartment linked to the plasma by a first-order equilibration process with rate constant $k_{e0}=0.80$ $\\text{h}^{-1}$. The pharmacodynamic effect is described by a monotonic increasing maximal effect model, $E(t)=E_{0}+E_{\\max}\\,\\frac{C_{e}(t)}{EC_{50}+C_{e}(t)}$, where $E_{0}=10$ arbitrary units, $E_{\\max}=50$ arbitrary units, and $EC_{50}=5$ mg/L. Assume the effect-site concentration satisfies the standard effect-compartment mass balance with initial condition $C_{e}(0)=0$ and that plasma concentration follows first-order elimination with $C_{p}(0)=C_{0}$.\n\nUsing only first principles of mass balance and first-order kinetics, derive the time $t^{*}$ at which the pharmacodynamic effect $E(t)$ reaches its peak after the bolus. Then compute the numerical value of the time lag between the peak plasma concentration and the peak effect. Express your final numerical answer in hours and round your answer to four significant figures.",
            "solution": "The problem statement has been analyzed and is deemed valid. It is scientifically grounded in established principles of pharmacokinetics and pharmacodynamics, is well-posed with all necessary parameters and conditions provided, and is objectively formulated. The model described is a standard one-compartment pharmacokinetic model linked to a single effect-site compartment, which is a common and solvable problem in the field.\n\nThe problem asks for the time lag between the peak plasma concentration and the peak pharmacodynamic effect. This requires the derivation of the time course of both the plasma concentration, $C_p(t)$, and the effect-site concentration, $C_e(t)$.\n\nFirst, we establish the time course of the plasma concentration, $C_p(t)$. The drug is administered as a single intravenous bolus dose, $D$, into a system described by a one-compartment model with first-order elimination. The governing differential equation for the plasma concentration is:\n$$\n\\frac{dC_p}{dt} = -k_{\\text{el}} C_p(t)\n$$\nwhere $k_{\\text{el}}$ is the first-order elimination rate constant. The initial condition at time $t=0$ is $C_p(0) = C_0$, where $C_0$ is the initial concentration resulting from the bolus dose $D$ distributed in the apparent volume of distribution $V$. Thus, $C_0 = D/V$.\nThe solution to this first-order linear ordinary differential equation is an exponential decay function:\n$$\nC_p(t) = C_0 \\exp(-k_{\\text{el}} t)\n$$\nThe peak plasma concentration, by the nature of an intravenous bolus injection, occurs at the moment of injection, $t = 0$. Therefore, the time of peak plasma concentration is $t_{\\text{peak, plasma}} = 0$.\n\nNext, we derive the time course of the effect-site concentration, $C_e(t)$. The effect-site compartment is linked to the plasma via a first-order process, with an equilibration rate constant $k_{e0}$. The rate of change of the effect-site concentration is described by the mass balance equation:\n$$\n\\frac{dC_e}{dt} = k_{e0} C_p(t) - k_{e0} C_e(t)\n$$\nThis equation states that the change in $C_e$ is the rate of drug entry from the plasma ($k_{e0} C_p(t)$) minus the rate of drug exit from the effect site ($k_{e0} C_e(t)$). Substituting the expression for $C_p(t)$, we obtain:\n$$\n\\frac{dC_e}{dt} = k_{e0} C_0 \\exp(-k_{\\text{el}} t) - k_{e0} C_e(t)\n$$\nThis can be rewritten as a standard first-order linear inhomogeneous differential equation:\n$$\n\\frac{dC_e}{dt} + k_{e0} C_e(t) = k_{e0} C_0 \\exp(-k_{\\text{el}} t)\n$$\nWe solve this equation using the method of integrating factors. The integrating factor is $I(t) = \\exp(\\int k_{e0} dt) = \\exp(k_{e0} t)$. Multiplying the differential equation by $I(t)$ gives:\n$$\n\\exp(k_{e0} t) \\frac{dC_e}{dt} + k_{e0} \\exp(k_{e0} t) C_e(t) = k_{e0} C_0 \\exp(k_{e0} t) \\exp(-k_{\\text{el}} t)\n$$\nThe left side is the derivative of a product:\n$$\n\\frac{d}{dt} \\left( C_e(t) \\exp(k_{e0} t) \\right) = k_{e0} C_0 \\exp((k_{e0} - k_{\\text{el}}) t)\n$$\nIntegrating both sides with respect to time from $0$ to $t$:\n$$\n\\int_0^t \\frac{d}{d\\tau} \\left( C_e(\\tau) \\exp(k_{e0} \\tau) \\right) d\\tau = \\int_0^t k_{e0} C_0 \\exp((k_{e0} - k_{\\text{el}}) \\tau) d\\tau\n$$\nProvided that $k_{e0} \\neq k_{\\text{el}}$, which is true for the given values ($k_{e0} = 0.80 \\, \\text{h}^{-1}$ and $k_{\\text{el}} = 0.25 \\, \\text{h}^{-1}$):\n$$\n\\left[ C_e(\\tau) \\exp(k_{e0} \\tau) \\right]_0^t = k_{e0} C_0 \\left[ \\frac{\\exp((k_{e0} - k_{\\text{el}}) \\tau)}{k_{e0} - k_{\\text{el}}} \\right]_0^t\n$$\nApplying the limits of integration and the initial condition $C_e(0) = 0$:\n$$\nC_e(t) \\exp(k_{e0} t) - C_e(0) \\exp(0) = \\frac{k_{e0} C_0}{k_{e0} - k_{\\text{el}}} \\left( \\exp((k_{e0} - k_{\\text{el}}) t) - 1 \\right)\n$$\n$$\nC_e(t) \\exp(k_{e0} t) = \\frac{k_{e0} C_0}{k_{e0} - k_{\\text{el}}} (\\exp(k_{e0} t)\\exp(-k_{\\text{el}} t) - 1)\n$$\nMultiplying by $\\exp(-k_{e0} t)$ to isolate $C_e(t)$:\n$$\nC_e(t) = \\frac{k_{e0} C_0}{k_{e0} - k_{\\text{el}}} (\\exp(-k_{\\text{el}} t) - \\exp(-k_{e0} t))\n$$\nThe pharmacodynamic effect $E(t)$ is given by $E(t) = E_0 + E_{\\max} \\frac{C_e(t)}{EC_{50} + C_e(t)}$. To find the time of peak effect, we must find the maximum of $E(t)$. We can examine the derivative of $E$ with respect to $C_e$:\n$$\n\\frac{dE}{dC_e} = E_{\\max} \\frac{d}{dC_e} \\left( \\frac{C_e}{EC_{50} + C_e} \\right) = E_{\\max} \\frac{(EC_{50} + C_e)(1) - C_e(1)}{(EC_{50} + C_e)^2} = \\frac{E_{\\max} EC_{50}}{(EC_{50} + C_e)^2}\n$$\nSince $E_{\\max}  0$ and $EC_{50}  0$, the derivative $\\frac{dE}{dC_e}$ is always positive. This signifies that $E(t)$ is a monotonically increasing function of $C_e(t)$. Consequently, the peak effect $E_{\\text{peak}}$ occurs at the same time as the peak effect-site concentration $C_{e, \\text{peak}}$. Let this time be $t^*$.\n\nTo find $t^*$, we set the derivative of $C_e(t)$ with respect to time equal to zero. From the mass balance equation, $\\frac{dC_e}{dt} = k_{e0} C_p(t) - k_{e0} C_e(t)$. At the peak, $\\frac{dC_e}{dt}|_{t=t^*} = 0$, which implies $k_{e0} C_p(t^*) = k_{e0} C_e(t^*)$, or more simply, $C_p(t^*) = C_e(t^*)$.\nAlternatively, we can differentiate the explicit solution for $C_e(t)$:\n$$\n\\frac{dC_e}{dt} = \\frac{k_{e0} C_0}{k_{e0} - k_{\\text{el}}} \\frac{d}{dt} (\\exp(-k_{\\text{el}} t) - \\exp(-k_{e0} t))\n$$\n$$\n\\frac{dC_e}{dt} = \\frac{k_{e0} C_0}{k_{e0} - k_{\\text{el}}} (-k_{\\text{el}} \\exp(-k_{\\text{el}} t) + k_{e0} \\exp(-k_{e0} t))\n$$\nSetting $\\frac{dC_e}{dt} = 0$ at $t = t^*$:\n$$\n-k_{\\text{el}} \\exp(-k_{\\text{el}} t^*) + k_{e0} \\exp(-k_{e0} t^*) = 0\n$$\n$$\nk_{e0} \\exp(-k_{e0} t^*) = k_{\\text{el}} \\exp(-k_{\\text{el}} t^*)\n$$\nTaking the natural logarithm of both sides:\n$$\n\\ln(k_{e0}) - k_{e0} t^* = \\ln(k_{\\text{el}}) - k_{\\text{el}} t^*\n$$\n$$\n\\ln(k_{e0}) - \\ln(k_{\\text{el}}) = t^* (k_{e0} - k_{\\text{el}})\n$$\n$$\n\\ln\\left(\\frac{k_{e0}}{k_{\\text{el}}}\\right) = t^* (k_{e0} - k_{\\text{el}})\n$$\nSolving for $t^*$:\n$$\nt^* = \\frac{\\ln(k_{e0} / k_{\\text{el}})}{k_{e0} - k_{\\text{el}}}\n$$\nThis expression gives the time of peak effect. The time lag between the peak plasma concentration ($t=0$) and the peak effect is simply $t^* - 0 = t^*$.\n\nNow, we substitute the numerical values provided in the problem:\n$k_{\\text{el}} = 0.25 \\, \\text{h}^{-1}$\n$k_{e0} = 0.80 \\, \\text{h}^{-1}$\n\nThe time of peak effect is:\n$$\nt^* = \\frac{\\ln(0.80 / 0.25)}{0.80 - 0.25} = \\frac{\\ln(3.2)}{0.55} \\, \\text{h}\n$$\nCalculating the numerical value:\n$$\n\\ln(3.2) \\approx 1.1631508\n$$\n$$\nt^* \\approx \\frac{1.1631508}{0.55} \\approx 2.1148196 \\, \\text{h}\n$$\nThe problem requires the answer to be rounded to four significant figures.\n$$\nt^* \\approx 2.115 \\, \\text{h}\n$$\nThe time lag between peak plasma concentration and peak effect is this value, $t^*$.",
            "answer": "$$\n\\boxed{2.115}\n$$"
        }
    ]
}